{
    "clinical_study": {
        "@rank": "159638", 
        "arm_group": [
            {
                "arm_group_label": "Angio-guided PCI", 
                "arm_group_type": "Active Comparator", 
                "description": "Angio-guided PCI"
            }, 
            {
                "arm_group_label": "OCT-guided PCI", 
                "arm_group_type": "Experimental", 
                "description": "OCT-guided PCI"
            }, 
            {
                "arm_group_label": "N-BES (Nobori\u00ae)", 
                "arm_group_type": "Active Comparator", 
                "description": "N-BES (Nobori\u00ae)"
            }, 
            {
                "arm_group_label": "EES (Xience Prime\u00ae)", 
                "arm_group_type": "Experimental", 
                "description": "EES (Xience Prime\u00ae)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is 1> to compare neointimal stent coverage after OCT-guided vs.\n      Angio-guided PCI, 2> to compare neointimal stent coverage at 3 months after EES (Xience\n      Prime\u00ae) vs N-BES (Nobori\u00ae) implantation, and 3> to determine the duration of dual\n      antiplatelet therapy by OCT measurement at 3 months."
        }, 
        "brief_title": "DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents Versus Biolimus A9-eluting Stents; DETECT-OCT Trial", 
        "completion_date": {
            "#text": "November 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Ischemic Heart Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Heart Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients \u2265 20 years old\n\n          -  Patients with ischemic heart disease who are considered for coronary\n             revascularization with stent implantation.\n\n          -  Significant coronary de novo lesion (stenosis > 70% by quantitative angiographic\n             analysis) treated by single DES \u2264 25mm\n\n          -  Reference vessel diameter of 2.5 to 3.5 mm by operator assessment\n\n        Exclusion Criteria:\n\n          -  Complex lesion morphologies such as arota-ostial, unprotected left main, chronic\n             total occlusion,    graft, thrombosis, and restenosis\n\n          -  Reference vessel diameter < 2.5 mm or > 4.0mm\n\n          -  Heavy calcified lesions (definite calcified lesions on angiogram)\n\n          -  Lesions requiring 2 or more DES\n\n          -  Primary PCI for STEMI\n\n          -  Contraindication to anti-platelet agents\n\n          -  Treated with any DES within 3 months at other vessel\n\n          -  Creatinine level \u2265 2.0 mg/dL or ESRD\n\n          -  Severe hepatic dysfunction (3 times normal reference values)\n\n          -  Pregnant women or women with potential childbearing\n\n          -  Life expectancy < 1 year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "1100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01752894", 
            "org_study_id": "1-2012-0047"
        }, 
        "intervention": [
            {
                "arm_group_label": "Angio-guided PCI", 
                "intervention_name": "Angio-guided intervention", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "OCT-guided PCI", 
                "intervention_name": "OCT-guided intervention", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "N-BES (Nobori\u00ae)", 
                "intervention_name": "PCI with N-BES (Nobori\u00ae) under angio-guide or OCT guide", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "EES (Xience Prime\u00ae)", 
                "intervention_name": "PCI with EES (Xience Prime\u00ae) under angio-guide or OCT guide", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "contact": {
                "email": "MKHONG61@yuhs.ac", 
                "last_name": "MYEONG-KI HONG, MD", 
                "phone": "82-2-2228-8458"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "overall_contact": {
            "email": "MKHONG61@yuhs.ac", 
            "last_name": "MYEONG-KI HONG, MD", 
            "phone": "82-2-2228-8458"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Neointimal coverage", 
            "safety_issue": "Yes", 
            "time_frame": "at 3 month-OCT after stent implantation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01752894"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}